Thomas Frank E insider trades
Thomas Frank E has filed 21 Form 4s with the SEC that we hold, for Larimar Therapeutics, Inc. (LRMR) (Director), ORTX (See Remarks) and Spero Therapeutics, Inc. (SPRO) (Director). Across all of them we count 3 purchases worth $54.5K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($25.0K) and 0 sales ($0). The largest single trade was a purchase of 5,000 shares of Larimar Therapeutics, Inc. worth $25.0K, dated 2026-02-27. The first filing on our record is dated 2021-08-18 and the latest 2026-06-25.
Larimar Therapeutics, Inc. (LRMR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-02-14 | P, purchase reported on Form 4 | 2,000 | $22.0K | 2024-02-15 |
| 2026-02-27 | P, purchase reported on Form 4 | 5,000 | $25.0K | 2026-03-02 |
ORTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-01 | P, purchase reported on Form 4 | 10,000 | $7.5K | 2022-04-04 |
Spero Therapeutics, Inc. (SPRO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1242616) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms